Literature DB >> 20419493

Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass?

Philip Dilks1, Priya Narayanan, Rodney Reznek, Anju Sahdev, Andrea Rockall.   

Abstract

OBJECTIVES: Our aim was to establish threshold criteria based on quantitative DCE-MRI data as independent predictors of malignancy in a complex (solid, solid/cystic) ovarian mass.
METHODS: The MRI of 26 lesions in 25 patients with a complex ovarian mass (age range, 17-80 years; mean 43 years) was retrospectively reviewed and correlated with histology following resection. Cases with solid tumour components, definitive histology and relevant dynamic imaging were included. These were categorised into two groups, benign (N = 14) and malignant (N = 12). Following dynamic contrast-enhanced imaging, regions of interest were drawn around the solid tumour component. Maximum actual enhancement (SImax), maximum relative enhancement (SIrel), wash-in rate (WIR) and SImax (tumour)/SImax (psoas) ratio were analysed. Threshold criteria for malignancy were established.
RESULTS: There was a significant difference in SImax (p < 0.001), SIrel (p < 0.05), WIR (p < 0.001) and SImax (tumour)/SImax (psoas) between the two groups. Optimal threshold criteria for malignancy were established; SImax > or = 250 or SImax (tumour)/SImax (psoas) > or = 2.35 divided the two groups with 100% sensitivity, specificity and accuracy.
CONCLUSION: Threshold criteria established in this preliminary study using quantitative DCE-MRI provide an accurate method for the prediction of malignancy, particularly in preoperative indeterminate cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419493     DOI: 10.1007/s00330-010-1795-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

Review 2.  Detection and characterization of adnexal masses.

Authors:  Stacey A Funt; Lucy E Hann
Journal:  Radiol Clin North Am       Date:  2002-05       Impact factor: 2.303

3.  Gynecologic sonography. Report of the ultrasonography task force. Council on Scientific Affairs, American Medical Association.

Authors: 
Journal:  JAMA       Date:  1991-06-05       Impact factor: 56.272

4.  Subtraction imaging: applications for nonvascular abdominal MRI.

Authors:  Amit Newatia; Gaurav Khatri; Barak Friedman; John Hines
Journal:  AJR Am J Roentgenol       Date:  2007-04       Impact factor: 3.959

5.  MRI of sonographically indeterminate adnexal masses.

Authors:  Saroja Adusumilli; Hero K Hussain; Elaine M Caoili; William J Weadock; John P Murray; Timothy D Johnson; Qixuan Chen; Benoit Desjardins
Journal:  AJR Am J Roentgenol       Date:  2006-09       Impact factor: 3.959

6.  Risk of malignancy index in the preoperative evaluation of pelvic masses.

Authors:  B R Obeidat; Z O Amarin; J A Latimer; R A Crawford
Journal:  Int J Gynaecol Obstet       Date:  2004-06       Impact factor: 3.561

7.  Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women.

Authors:  F A Strigini; A Gadducci; B Del Bravo; M Ferdeghini; A R Genazzani
Journal:  Gynecol Oncol       Date:  1996-04       Impact factor: 5.482

8.  Borderline ovarian malignancy: ultrasound and fast dynamic MR findings.

Authors:  P B Van Vierzen; L F Massuger; S H Ruys; J O Barentsz
Journal:  Eur J Radiol       Date:  1998-09       Impact factor: 3.528

9.  Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.

Authors:  Iclal Ocak; Marcelino Bernardo; Greg Metzger; Tristan Barrett; Peter Pinto; Paul S Albert; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

10.  Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.

Authors:  J Ren; Y Huan; H Wang; Y-J Chang; H-T Zhao; Y-L Ge; Y Liu; Y Yang
Journal:  Clin Radiol       Date:  2007-11-19       Impact factor: 2.350

View more
  13 in total

1.  The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.

Authors:  Xian Li; Jun-Li Hu; Lai-Min Zhu; Xin-Hai Sun; Hua-Qiang Sheng; Ning Zhai; Xi-Bin Hu; Chu-Ran Sun; Bin Zhao
Journal:  Tumour Biol       Date:  2015-02-28

2.  Use of an internal reference in semi-quantitative dynamic contrast-enhanced MRI (DCE MRI) of indeterminate adnexal masses.

Authors:  Y Z Tang; L Benardin; T C Booth; M E Miquel; P Dilks; A Sahdev; A G Rockall
Journal:  Br J Radiol       Date:  2014-09-19       Impact factor: 3.039

3.  Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?

Authors:  S M Mansour; S Saraya; Y El-Faissal
Journal:  Br J Radiol       Date:  2015-06-17       Impact factor: 3.039

4.  Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation.

Authors:  Livia Bernardin; Philip Dilks; Sidath Liyanage; Marc E Miquel; Anju Sahdev; Andrea Rockall
Journal:  Eur Radiol       Date:  2011-11-18       Impact factor: 5.315

5.  Assessment of the performance of the O-RADS MRI score for the evaluation of adnexal masses, with technical notes.

Authors:  Patrick Nunes Pereira; Adriana Yoshida; Luís Otavio Sarian; Ricardo Hoelz de Oliveira Barros; Rodrigo Menezes Jales; Sophie Derchain
Journal:  Radiol Bras       Date:  2022 May-Jun

Review 6.  O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.

Authors:  Elizabeth A Sadowski; Isabelle Thomassin-Naggara; Andrea Rockall; Katherine E Maturen; Rosemarie Forstner; Priyanka Jha; Stephanie Nougaret; Evan S Siegelman; Caroline Reinhold
Journal:  Radiology       Date:  2022-01-18       Impact factor: 11.105

7.  Role of New Functional MRI Techniques in the Diagnosis, Staging, and Followup of Gynecological Cancer: Comparison with PET-CT.

Authors:  Elena Alvarez Moreno; Mar Jimenez de la Peña; Raquel Cano Alonso
Journal:  Radiol Res Pract       Date:  2012-01-18

8.  Enhancement of ovarian malignancy on clinical contrast enhanced MRI studies.

Authors:  Harpreet K Pannu; Weining Ma; Emily Craig Zabor; Chaya S Moskowitz; Richard R Barakat; Hedvig Hricak
Journal:  ISRN Obstet Gynecol       Date:  2013-02-13

Review 9.  Added Value of Assessing Adnexal Masses with Advanced MRI Techniques.

Authors:  I Thomassin-Naggara; D Balvay; A Rockall; M F Carette; M Ballester; E Darai; M Bazot
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

10.  Hyaluronic acid-modified magnetic iron oxide nanoparticles for MR imaging of surgically induced endometriosis model in rats.

Authors:  He Zhang; Jingchao Li; Wenjie Sun; Yong Hu; Guofu Zhang; Mingwu Shen; Xiangyang Shi
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.